Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

S&P Biotech SPDR (XBI)

85.62 -0.09 (-0.11%)

10/20/2017  4:00pm

Open:

85.66

Pre. Close:

85.71

High:

85.94

Low:

84.72

Volume:

5,151,715

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

86.26 - 87.33

87.33 - 88.21

Low:

82.42 - 83.65

83.65 - 84.67

Close:

84.23 - 85.82

85.82 - 87.12

Technical analysis  (as of: 2017-10-20 4:43:12 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 101.24     One year: 103.93

Support:

Support1: 82.96    Support2: 69.02

Resistance:

Resistance1: 86.68    Resistance2: 88.98

Pivot:

87.25

Moving Averages:

MA(5): 86.24     MA(20): 86.66

MA(100): 79.93     MA(250): 71.54

MACD:

MACD(12,26): 0.74     Signal(12,26,9): 1.18

%K %D:

%K(14,3): 28.29     %D(3): 41.75

RSI:

RSI(14): 49.54

52-Week:

High: 88.98  Low: 53.15  Change(%): 44.8

Average Vol(K):

3-Month: 298628  10-Days 74076

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
XBI has closed above bottom band by 3.9%. Bollinger Bands are 46.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to XBI's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 13 Oct 2017 15:11:15 GMT
SPDR S&P Biotech ETF Experiences Big Outflow

Sat, 16 Sep 2017 11:03:45 GMT
SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI

Thu, 05 Oct 2017 11:37:30 GMT
Pete Najarian Sees Unusual Options Activity In SPDR S&P Biotech

Fri, 23 Jun 2017 12:11:15 GMT
Is the SPDR S&P Biotech (ETF) (XBI) Done Running?

Wed, 14 Jun 2017 12:11:15 GMT
The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA

Industry:  NA

Shares Out. (M)

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.